T1	intervention 0 27	Topical silver sulfadiazine
T2	condition 50 66	acute dermatitis
T3	eligibility 337 439	patients with breast cancer referred for radiotherapy after treatment with mastectomy and chemotherapy
T4	intervention-participants 497 499	51
T5	control 505 512	control
T6	control-participants 518 520	51
T9	cv-bin-abs 947 950	Two
T13	outcome 1190 1216	total score of skin injury
T15	outcome 1513 1554	severity of radiation-induced skin injury
T8	iv-cont-mean 1282 1286	5.49
T16	iv-cont-sd 1289 1293	1.02
T17	cv-cont-mean 1298 1302	7.21
T18	cv-cont-sd 1305 1309	1.76
T10	outcome 981 993	discontinued
T11	outcome 1122 1139	severe dermatitis
